Statistics for Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)
Total visits
| views | |
|---|---|
| Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial) | 3 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 2 |
| May 2025 | 0 |
| June 2025 | 1 |
| July 2025 | 0 |
Top country views
| views | |
|---|---|
| United States | 2 |
| India | 1 |
Top city views
| views | |
|---|---|
| Fishers | 2 |
| Jaipur | 1 |